Previous webinar

Mar 14, 2024

1 PM (CET)




Kicking off the 2024 webinar series, our invited speakers will talk through complement diseases and C3G particularly.

Watch our recorded session


Dr. Bjoern Cochlovius

CEO Eleva

Eleva Insight

Eleva’s origins and experience, who we are today, and our ambitions for the future.

Prof. Dr. Peter Zipfel

Head of department infection biology; Leibniz-Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena

Factor H and complement in a nutshell

The role of Factor H in the complement system and in complement-mediated diseases

Prof. Dr. Dinesh Khullar

Chairman Nephrology & Renal Transplant Medicine at Max Superspeciality Hospital Saket New Delhi

G3 Glomerulopathy in India

Prevalence, immunological and genetic differences of C3 Glomerulopathy in India.

Did you miss the video?

Watch the video

Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.

Our webinar series offers firsthand insights from experts, scientists and clinicians about C3 Glomerulopathy (C3G) such as epidemiology, diagnosis, treatment, management and coping strategies. You will hear about all the relevant aspects, including Eleva’s initiatives to develop new treatment options for this ultrarare disease with high unmet medical need. Join the series for regular updates on Eleva’s clinical development efforts.

Stay in the loop

Next webinars

  • Jun 13, 2024

    ...will focus on diagnostics and the disease spectrum of C3 Glomerulopathy, zooming in on histological spectrum.
  • Oct 17, 2024 dedicated to pediatric case reports and Eleva’s Factor H (CPV-104) study program.
  • Dec 5, 2024

    ...will zoom in on spectrum 2 and provide more insight into Eleva’s technology.

Back to